مرور Volume 20, Issue 10 بر اساس موضوع "Cancer biology"
در حال نمایش موارد 1 - 6 از 6
-
Clinico-Pathological Characteristics and Mutational Analysis of Gastrointestinal Stromal Tumors from India: A Single Institution Experience
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Background: Gastrointestinal stromal tumor (GIST) is the most common type of mesenchymal neoplasm of gastrointestinal tract. The incidence of GIST in India is not known and its treatment strategy in our country is ...
-
Comparative Study of Blood, Tissue and Serum Levels of Carcinoembryonic Antigen (CEA) Detection in Breast Cancer
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Background: Carcinoembryonic antigen (CEA) detection was evaluated in breast cancer (BC). The statistical correlation between the CEA mRNA and clinico-pathological features in the peripheral blood (PB) and tissue samples of ...
-
High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Background: DNA promoter methylation is widely explored epigenetic phenomena, known to effect gene expression and further perturbation in cellular homeostasis. Myriad of studies have leveraged promoter methylation and its ...
-
Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Objective: Minichromosome maintenance complex (MCM) proteins are essential for the process of DNA replication and cell division. This study aimed to evaluate MCM genes expression profiles and MCM2 protein in ...
-
Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Background: In this era of developing targeted therapies and immunotherapies as a treatment for renal cell carcinoma (RCC), Programmed death ligand 1 (PDL1) as a novel biomarker for RCC is analysed in our study. About 90% ...
-
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
(West Asia Organization for Cancer Prevention (WAOCP), 2019-10-01)Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown ...



